AA
ACTU icon

ACT Advisors’s Actuate Therapeutics ACTU Stock Holding History

ACT Advisors’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-12,877
Closed -$19.7K – 94
2026
Q2 		$19.7K Buy
+12,877
New +$29.8K 0.01% 77

Other funds holding ACTU

GG
Gleason Group Prospect, Kentucky $1.13B AUM 12.68% 1-Year Est. Return
GRWP
Green Ridge Wealth Planning Montville, New Jersey $249M AUM 26.89% 1-Year Est. Return

ACT Advisors's ACTU Position: Q3 2026 in Review

ACT Advisors sold out of Actuate Therapeutics (ACTU) in Q3 2026, closing a stake of 12,877 shares — an estimated $19.7K sold.

ACT Advisors first reported a position in ACTU in Q2 2026 and held it in 1 quarter. The position peaked at $19.7K in Q2 2026. 2 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.

  • ACT Advisors reported no remaining Actuate Therapeutics position as of Q3 2026 after selling out during the quarter.
  • ACT Advisors sold 12,877 Actuate Therapeutics shares in Q3 2026, an estimated $19.7K.
  • ACT Advisors first reported a position in Actuate Therapeutics in Q2 2026 and held it in 1 quarter.
  • ACT Advisors's Actuate Therapeutics position peaked at $19.7K in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.

Based on ACT Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.